The Scientist

» MHC molecules

Most Recent

image: Second Contagious Cancer Found in Tasmanian Devils

Second Contagious Cancer Found in Tasmanian Devils

By | December 29, 2015

A second fatal, transmissible cancer has been identified in the already endangered species.  

0 Comments

image: Poor Little Devils

Poor Little Devils

By | November 1, 2014

See the devastating infectious cancer that may drive the Tasmanian Devil to extinction.

0 Comments

image: The Devil’s Details

The Devil’s Details

By | November 1, 2014

With the iconic Australian marsupial carnivore on the brink of extinction, Tasmanian researchers race to unlock the immunological mysteries of a disease threatening the species.

0 Comments

image: Beyond Expectation

Beyond Expectation

By | September 1, 2011

Philippa “Pippa” Marrack has made some unanticipated discoveries about how the immune system functions in health and disease.

9 Comments

image: Baruj Benacerraf Dies

Baruj Benacerraf Dies

By | August 3, 2011

The Nobel Prize winner who discovered the gene that encodes the major histocompatibility complex passes away at age 90.

0 Comments

image: Thymus Finder

Thymus Finder

By | July 1, 2011

Editor’s Choice in Immunology

0 Comments

image: Foresight

Foresight

By | July 1, 2011

Studying the earliest events in visual development, Carla Shatz has learned the importance of looking at one’s data with open eyes—and an open mind.

12 Comments

Popular Now

  1. UC Berkeley Receives CRISPR Patent in Europe
    Daily News UC Berkeley Receives CRISPR Patent in Europe

    The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S.

  2. DNA Replication Errors Contribute to Cancer Risk
  3. Should Healthy People Have Their Exomes Sequenced?
    Daily News Should Healthy People Have Their Exomes Sequenced?

    With its announced launch of a whole-exome sequencing service for apparently healthy individuals, Ambry Genetics is the latest company to enter this growing market. But whether these services are useful for most people remains up for debate.  

  4. Rethinking a Cancer Drug Target
    Daily News Rethinking a Cancer Drug Target

    The results of a CRISPR-Cas9 study suggest that MELK—a protein thought to play a critical role in cancer—is not necessary for cancer cell survival.

Business Birmingham